IDStewardship

  • Home
  • Articles
  • LEARN ANTIBIOTICS
  • Study Guide
  • Resources
  • Q&A
  • #ASPchat
  • Contributors
  • About

Top New Infectious Diseases and Antimicrobial Stewardship Journal Articles: December 2019

In this article top new infectious diseases and antimicrobial stewardship journal articles are identified. Here are our picks to share with you for November 2019.



Written By: Bassam Ghanem, Pharm.D., MS, BCPS

Edited By: Timothy P. Gauthier, Pharm.D., BCPS-AQ ID


Last updated: 5 December 2019

In this monthly column two pharmacists with advanced training in infectious diseases and antimicrobial stewardship identify top new journal articles published in the peer-reviewed scientific literature. Many of these are identified, shared, and discussed via Twitter. The authors can be found on Twitter @ABsteward (B.G.) & @IDstewardship (T.G.).

It is very hard to keep up with all of the new publications that come out each month. We hope this can assist people in identifying new articles of interest. We additionally hope it can serve as a place to come back to if you find something of interest and need a link to it.

1. Safety and efficacy of fidaxomicin and vancomycin in children and adolescents with Clostridioides (Clostridium) difficile infection: a phase 3, multicenter, randomized, single-blind clinical trial (SUNSHINE) | CID

https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciz1149/5644102

SUNSHINE RCT concluded that Fidaxomicin was well tolerated and demonstrated significantly higher rates of global cure compared with vancomycin, in children and adolescents with C. difficile infection.

2. Colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia (Magic Bullet study): an investigator-driven, open-label, randomized, noninferiority controlled trial | CC

https://ccforum.biomedcentral.com/articles/10.1186/s13054-019-2627-y

Magic Bullet RCT did not demonstrate the noninferiority of colistin compared with meropenem, both combined with levofloxacin, in terms of efficacy in the empirical treatment of late VAP but demonstrated the greater nephrotoxicity of colistin.

3. Vancomycin area under the curve to minimum inhibitory concentration ratio predicting clinical outcome: a systematic review and meta-analysis with pooled sensitivity and specificity | CMI

https://www.sciencedirect.com/science/article/abs/pii/S1198743X19305841

This systematic review and meta-analysis concluded that vancomycin AUC:MIC performance was modest and inconsistent. Additionally it found the majority of studies included failed to demonstrate a relationship between AUC:MIC and positive clinical outcome.

4. Beta-lactam antibiotic versus combined Beta-lactam antibiotic and single-daily dosing regimens of aminoglycosides for the treatment of serious infections: a meta-analysis | IJAA

https://www.sciencedirect.com/science/article/pii/S0924857919303000

This systematic review and meta-analysis concluded that existing evidence suggests no added survival benefit from a single daily dosing regimen of an aminoglycoside when combined with beta-lactam antibiotics.

5. Adjunctive Rifampin Therapy For Diabetic Foot Osteomyelitis in the Veterans Health Administration | JAMA Netw Open

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2019.16003

This cohort study found that patients received rifampin for diabetic foot osteomyelitis experienced lower rates of death and amputation than patients not treated with rifampin, which remained significant after adjustment for confounders.



Additional New & Notable Publications

Long-term impact of an educational antimicrobial stewardship programme in primary care on infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in the community: an interrupted time-series analysis | Lancet ID

Colistin Resistance Development Following Colistin-Meropenem Combination Therapy vs. Colistin Monotherapy in Patients with Infections Caused by Carbapenem-Resistant Organisms | CID

Longitudinal, strain-specific Staphylococcus aureus introduction and transmission events in households of children with community-associated meticillin-resistant S aureus skin and soft tissue infection: a prospective cohort study | Lancet ID

Decreases in antimicrobial use associated with multihospital implementation of electronic antimicrobial stewardship tools | CID

The Changing Epidemiology of Candidemia in the United States: Injection Drug Use as an Increasingly Common Risk Factor Active Surveillance in Selected Sites, United States, 2014-17 | CID

Risk factors for mortality among patients with Pseudomonas aeruginosa bacteremia a retrospective multicenter study | IJAA

Improved Antibiotic Prescribing within a Veterans Affairs Primary Care System through a Multifaceted Intervention Centered on Peer Comparison of Overall Antibiotic Prescribing Rates | AAC

Impact of an antimicrobial stewardship bundle for uncomplicated gram-negative bacteremia | OFID

Aminoglycoside versus carbapenem or piperacillin/tazobactam treatment for bloodstream infections of urinary source caused by Gram-negative ESBL-producing Enterobacteriaceae | JAC

Bloodstream infection caused by KPC-producing Klebsiella pneumoniae resistant to ceftazidime/avibactam: Epidemiology and genomic characterization | CMI

Do vegetarians less frequently carry ESBL/ pAmpC-producing Escherichia coli/ Klebsiella pneumoniae compared with non-vegetarians? | JAC

Analysis of a high-prescribing state’s 2016 outpatient antibiotic prescriptions: Implications for outpatient antimicrobial stewardship interventions | ICHE

Does addition of intravenous metronidazole to oral vancomycin improve outcomes in Clostridioides difficile infection? | CID

Antimicrobial dosing in Critical Care: A pragmatic adult dosing nomogram | IJAA

Polymyxin susceptibility testing and interpretive breakpoints: Recommendations from the United States Committee on Antimicrobial Susceptibility Testing (USCAST) | AAC

Antimicrobial stewardship staffing: How much is enough? | ICHE

Sodium content of intravenous antibiotic preparations | OFID

Modern clinician-initiated clinical trials to determine optimal therapy for multi-drug resistant Gram-negative infections | CID

Infections caused by naturally AmpC-producing Enterobacteriaceae: can we use third generation cephalosporins? A narrative review | IJAA

Review of Guidelines for Dental Antibiotic Prophylaxis for Prevention of Endocarditis and Prosthetic Joint Infections and Need for Dental Stewardship | CID

Nudging In MicroBiology Laboratory Evaluation (NIMBLE): A scoping review | ICHE

What’s Old is New Again – Bacteriophage Therapy in the 21st century | AAC

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium | Lancet ID

Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP) | ICM


RECOMMENDED TO YOU


 

Filed Under: Infectious Diseases & Antimicrobial Stewardship

LEARN ANTIBIOTICS

Paperback Book

Let’s Talk Micro

STEWARD PINS

Subscribe

Sign up for the monthly newsletter!

We will never spam you. We want you to like us. By clicking the Subscribe button, you accept the Terms of Service and Privacy Policy.

Categories

  • COVID-19
  • Healthcare At Large
  • Infectious Diseases & Antimicrobial Stewardship
  • Pharmacy News
  • Reality Check
  • Residency & Training
  • Facebook
  • Instagram
  • LinkedIn
  • Pinterest
  • Tumblr
  • Twitter
  • YouTube

Recent Posts

  • Five Inconvenient Truths To Know About Infectious Diseases
  • Reality Versus Expectation: TikTok As An Educational Tool For Teaching Bugs & Drugs
  • Pharmacy Student Study Strategies To Maximizing Learning In 2025 And Beyond
  • 5 Things To Know About Interpreting MRSA Nares Swab Results
  • Five Tidbits From The Largest International Meeting Of Clinical Microbiologists & Infectious Diseases Specialists In 2025

More Articles

5 Quick Tips For Pharmacy Residents Preparing Manuscripts

5 Quick Tips For Pharmacy Residents Preparing Manuscripts

5 Quick Things To Know About Drug Shortages

5 Quick Things To Know About Drug Shortages

Something Cool & Something Lame With 5 Antibiotics

Something Cool & Something Lame With 5 Antibiotics

5 Neat Things From The World Of Antimicrobials

5 Neat Things From The World Of Antimicrobials

Tags

antibiotic Antibiotics antimicrobial stewardship bcps beta-lactam cancer Chemotherapy Clinical Controversies clinical pharmacist clinical pharmacy community pharmacist Critical Care emergency medicine Emoji Game fellowship figure1 Hepatitis C hospital pharmacist hospital pharmacy Infectious Disease infectious diseases Lifestyle MRSA NAPLEX Natural Disaster oncology pharmacist one-on-one penicillin allergy PGY2 pharmacy fellowship Pharmacy Job pharmacy practice pharmacy residency pharmacy school pharmacy student Pharmacy technician PK-PD Compass Predatory Journals Rapid Diagnostic Testing residency social media student pharmacist study table transplant Zika

Recent

  • Five Inconvenient Truths To Know About Infectious Diseases
  • Reality Versus Expectation: TikTok As An Educational Tool For Teaching Bugs & Drugs
  • Pharmacy Student Study Strategies To Maximizing Learning In 2025 And Beyond
  • 5 Things To Know About Interpreting MRSA Nares Swab Results
  • Five Tidbits From The Largest International Meeting Of Clinical Microbiologists & Infectious Diseases Specialists In 2025

Search

Copyright 2016-2020 By Charlie Rose, LLC © · IDStewardship.com · Copyright · Privacy Policy · Terms · Contact